dc.contributor.author |
Lena, G |
en |
dc.contributor.author |
Trapani, JA |
en |
dc.contributor.author |
Sutton, VR |
en |
dc.contributor.author |
Ciccone, A |
en |
dc.contributor.author |
Browne, KA |
en |
dc.contributor.author |
Smyth, MJ |
en |
dc.contributor.author |
Denny, William |
en |
dc.contributor.author |
Spicer, Julie |
en |
dc.date.accessioned |
2011-11-17T17:16:21Z |
en |
dc.date.issued |
2008-12-11 |
en |
dc.identifier.citation |
Journal of Medicinal Chemistry 51(23):7614-7624 11 Dec 2008 |
en |
dc.identifier.issn |
0022-2623 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/9218 |
en |
dc.description.abstract |
Dihydrofuro[3,4-c]pyridinones are the first class of small molecules reported to inhibit the cytolytic effects of the lymphocyte toxin perforin. A lead structure was identified from a high throughput screen, and a series of analogues were designed and prepared to explore structure−activity relationships around the core bicyclic thioxofuropyridinone and pendant furan ring. This resulted in the identification of a submicromolar inhibitor of the perforin-induced lysis of Jurkat T-lymphoma cells. |
en |
dc.language |
EN |
en |
dc.publisher |
American Chemical Society |
en |
dc.relation.ispartofseries |
Journal of Medicinal Chemistry |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from
http://www.sherpa.ac.uk/romeo/issn/0022-2623/ |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
CYTOTOXIC T-LYMPHOCYTES |
en |
dc.subject |
MEDIATED CYTOTOXICITY |
en |
dc.subject |
CELL-DEATH |
en |
dc.subject |
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
en |
dc.subject |
DERIVATIVES |
en |
dc.subject |
PATHWAY |
en |
dc.subject |
MECHANISMS |
en |
dc.subject |
ALLOGRAFTS |
en |
dc.subject |
DISCOVERY |
en |
dc.subject |
POTENT |
en |
dc.title |
Dihydrofuro[3,4-c]pyridinones as inhibitors of the cytolytic effects of the pore-forming glycoprotein perforin |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1021/jm801063n |
en |
pubs.issue |
23 |
en |
pubs.begin-page |
7614 |
en |
pubs.volume |
51 |
en |
dc.rights.holder |
Copyright: American Chemical Society |
en |
dc.identifier.pmid |
19007200 |
en |
pubs.end-page |
7624 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
116352 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Medical Sciences |
en |
pubs.org-id |
Auckland Cancer Research |
en |
pubs.org-id |
Science |
en |
pubs.org-id |
Science Research |
en |
pubs.org-id |
Maurice Wilkins Centre (2010-2014) |
en |
pubs.record-created-at-source-date |
2011-11-17 |
en |
pubs.dimensions-id |
19007200 |
en |